Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Autophagy in cancer development, immune evasion, and drug resistance
In the future, the company will deliver higher quality products to consumers in a more convenient and efficient way
Antimicrobial resistance: impacts, challenges, and future prospects
The use of a monoclonal antibody targeting circulating ANGPTL3 (evinacumab: trade name Evkeeza) demonstrated promise at lowering circulating levels of LDL in homozygous familial hypercholesterolemia (designated HoFH) patients
.webp)
US$ 22.03
US$ 23.76
US$ 25.52
US$ 20.92
US$ 24.90
US$ 28.56
US$ 23.70
US$ 27.55
US$ 28.95
US$ 25.48
US$ 22.89
